Investigation of the immunological effect of medication in patients with brain tumors
Phase 1
- Conditions
- Glioblastoma multiformeTherapeutic area: Diseases [C] - Cancer [C04]
- Registration Number
- EUCTR2022-002700-21-HU
- Lead Sponsor
- ational Institute of Oncology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 155
Inclusion Criteria
Glioblastoma multiforme
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 115
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 40
Exclusion Criteria
Any other current tumors or known tumors in the patient's medical
history .
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method